Myelodysplastic Syndrome
Mostrando 1-12 de 85 artigos, teses e dissertações.
-
1. Gaucher-like cells in myelodysplastic syndrome with ring sideroblasts
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
2. The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome
ABSTRACT Introduction: The myelodysplastic syndrome (MDS) represents a group of hematopoietic neoplasms that is characterized by clonal hematopoiesis, cytopenia and abnormal cellular maturation. Red cell distribution width (RDW) refers to the variation degree of erythrocyte size and it is a reflection of anisocytosis. Higher values have been linked to adver
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
3. The tale of lenalidomide clinical superiority over thalidomide and regulatory and cost-effectiveness issues
Resumo A Agência Nacional de Vigilância Sanitária (ANVISA) aprovou em abril de 2017 a lenalidomida (LEN) para o mieloma múltiplo (MM) e síndrome mielodisplásica. A ANVISA havia negado o registro em 2010, e indeferido um recurso apresentado em 2012. O motivo do indeferimento foi a falta de estudos comparativos de efetividade demonstrando que LEN era mai
Ciênc. saúde coletiva. Publicado em: 26/09/2019
-
4. Bartonella henselae bacteremia diagnosed post-mortem in a myelodysplastic syndrome patient
ABSTRACT This study involves a 49-year-old male, who for three years suffered with a myelodysplastic syndrome and who needed frequent blood transfusions. One day following a transfusion, he presented fever and abdominal pain. The fever became persistent and only improved temporarily with two cycles of intravenous ciprofloxacin. Nearly 120 days after beginnin
Rev. Inst. Med. trop. S. Paulo. Publicado em: 12/09/2019
-
5. Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
OBJECTIVES: To evaluate the effects of epoetin (EPO) alfa treatment on overall survival, event-free survival and response duration in patients with myelodysplastic syndrome (MDS) who were treated at a haematological referral centre in northeastern Brazil. METHODS: This was a retrospective cohort study of 36 patients diagnosed with MDS and treated with EPO
Clinics. Publicado em: 09/09/2019
-
6. Role of conventional cytogenetics in sequential karyotype analysis of myelodysplastic syndrome: a patient with der(1;7)(q10;p10)
Hematol., Transfus. Cell Ther.. Publicado em: 15/04/2019
-
7. Pyoderma gangrenosum and erythema elevatum diutinum associated with a high-risk myelodysplastic syndrome: case report
Hematol., Transfus. Cell Ther.. Publicado em: 2018-06
-
8. Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
Abstract Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in serum creatinine and transaminases, skin rashes, such as maculopapular and urticarial eruptions, have
An. Bras. Dermatol.. Publicado em: 2017
-
9. Splicing factor SF3B1 mutations and ring sideroblasts in myelodysplastic syndromes: a Brazilian cohort screening study
ABSTRACT Background: Myelodysplastic syndromes (MDS) comprise a group of malignant clonal hematologic disorders characterized by ineffective hematopoiesis and propensity for progression to acute myeloid leukemia. Acquired mutations in the gene encoding RNA splicing factor 3B subunit 1 (SF3B1) are highly associated with the MDS subtypes presenting ring sider
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12
-
10. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report
This study reports a case of a gonadotropin-releasing hormone agonist trigger in a young female with myelodysplastic syndrome (MDS) who underwent fertility preservation using random-start controlled ovarian stimulation. This method involves the stimulation of the ovary regardless of a patient's menstrual-cycle phase. A review of the related literature is als
Braz J Med Biol Res. Publicado em: 10/05/2016
-
11. Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q)
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-12
-
12. Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation
ABSTRACT Introduction: Patients submitted to hematopoietic stem cell transplantation have an increased risk of Clostridium difficile infection and multiple risk factors have been identi- fied. Published reports have indicated an incidence from 9% to 30% of transplant patients however to date there is no information about infection in these patients in Ch
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-12